This research highlights the benefits of laughter therapy as a non-pharmacological approach to reduce stress and anxiety, particularly during the COVID-19 pandemic. Laughter stimulates the release of mood-enhancing neurotransmitters such as dopamine and serotonin while reducing stress hormones like cortisol. It also improves sleep quality, reduces depressive symptoms, and enhances the overall quality of life. The study emphasizes laughter therapy as a cost-effective, universal intervention with significant mental health benefits across age groups and vulnerable populations.
Incorporate laughter therapy into daily routines by engaging in activities such as watching comedies or participating in group laughter sessions. This approach can enhance mental well-being and alleviate stress. While the evidence supports its effectiveness, further research is needed to understand its long-term impact on diverse populations.